Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTRAU: Plasmalyte Viaflo vs Saline in Trauma Patients
NCT03630224Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2019
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plasmalyte in acute kidney injury (AKI), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2019; status: terminated.
02
Drugs
plasmalyte
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03630224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03630224.